当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Pan-Quan Luo, Li-Xiang Zhang, Bai-Cheng Ding and A-man Xu
Background: Gastric Cancer (GC) is one of the deadliest cancers in China. And, it can be regulated by MicroRNAs (miRNAs) generally. miR-491-5p function as a tumor suppressor in different types of cancer, but we still don’t know the role of miR-491-5p in GC.
Methods: RT-PCR was used to detect the level of miR491-5p and its clinical vale, functional experiments including CCK-8 assay and transwell assay were performed. Furthermore, the underlying mechanism was explored through qRT-PCR and western blotting. The function of miR-491-5p was also identified in vivo.
Results: miR-491-5p was related with TNM stage, patients with high miR-491-5p had better prognosis. We found that high level of miR-491-5p caused a weak cell proliferation, migration and invasion abilities. In order to explore the role of miR-491-5p in vivo, we set a xenograft mouse model, and found that high level of miR-491-5p suppressed tumor growth. Moreover, we found that miR-491-5p regulate the tumor development thought regulate the expression of EMT (Epithelial-Mesenchymal Transition), cell adhesion genes and IFITM2.
Conclusions: miR491-5p is an important prognostic bio-marker, which can offer help for diagnosis and treat of GC patients, and miR-491-5p function as a tumor suppressor in GC both in vitro and in vivo.